Quick Answer
AIM ImmunoTech Inc. reported Net Income of -$13.96 million for fiscal year 2025.
AIM ImmunoTech Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$13.96M | +19.4% |
| 2024 | -$17.32M | +40.2% |
| 2023 | -$28.96M | -48.9% |
| 2022 | -$19.45M | -1.7% |
| 2021 | -$19.13M | -32.8% |
| 2020 | -$14.40M | -53.1% |
| 2019 | -$9.40M | +4.3% |
| 2018 | -$9.83M | -19.0% |
| 2017 | -$8.26M | -10.1% |
| 2016 | -$7.50M | +50.7% |
| 2015 | -$15.23M | +12.7% |
| 2014 | -$17.45M | -7.6% |
| 2013 | -$16.23M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.28M | +11.2% | -17.5% |
| June 30, 2025 | -$2.79M | -52.2% | +24.6% |
| March 31, 2025 | -$3.71M | +36.3% | -0.1% |
| September 30, 2024 | -$3.70M | +52.7% | -101.5% |
| June 30, 2024 | -$1.84M | +62.6% | +68.4% |
| March 31, 2024 | -$5.82M | -58.9% | +25.6% |
| September 30, 2023 | -$7.82M | -22.4% | -59.2% |
| June 30, 2023 | -$4.91M | -1.2% | -34.1% |
- AIM ImmunoTech Inc. showed an increase of +19.4% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, AIM ImmunoTech Inc.’s net income has grown by 14.0% (from -$16.23 million to -$13.96 million).
- The most recent figure is from AIM ImmunoTech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: